Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anjo.ai is an Israeli-based medical technology company specializing in AI-driven solutions for allergy management. The company's core offering is a wearable sensor integrated with a mobile platform that continuously monitors for physiological signs of anaphylaxis. Utilizing proprietary machine learning algorithms, the system provides real-time alerts to patients and emergency contacts, aiming to reduce the time to treatment during severe allergic reactions. Anjo.ai focuses on the food allergy market, providing a digital safety net that complements traditional emergency medications like epinephrine auto-injectors. The platform also facilitates data sharing with healthcare providers to improve long-term management of allergic conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anjo.ai.